WHAT IS NEW IN CANCER RESEARCH, PART 1.

There are several types of GYN (gynecologic) cancers. There will be articles about each one of them in the coming weeks.

Uterine/endometrial cancer affects an estimated 66,200 people in the United States. Uterine cancer is the fourth most common cancer for women in the United States. Worldwide, an estimated 417,367 people were diagnosed with uterine cancer in 2020.

Immunotherapy is designed to boost the body’s natural defenses to fight the cancer. There is interest in a specific area of immunotherapy called “checkpoint inhibitors,” such as PD-1 or CTLA4 targeted immunotherapies. They help activate the immune system and can shrink tumors. Some of these immunotherapies work better in combination with other treatment types. https://www.cancer.net/cancer-types/uterine-cancer/latest-research

Advent Health donation for the research programs is an effective, safe, and easy way to donate one-time or monthly. You may designate which cancer you want to support. Here is the link: https://give.adventhealth.com/give/564821/#!/donation/checkout

You can read my story and see my page at https://give.adventhealth.com/fundraiser/5552764

We see a day where people are screened with a simple blood draw for many cancers … That dream is closer to reality than I think any of us fully appreciate.” — Kevin Conroy, president and CEO, Exact Sciences

2 thoughts on “WHAT IS NEW IN CANCER RESEARCH, PART 1.

Leave a comment